Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 9, 2004, Pages 1185-1193

  Kadmon, Penny M ^a   Gruppuso, Philip A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Adolescents; Body mass index; Compliance; Hemoglobin A1c; Insulin; Metformin; Obesity; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DRUG APPROVAL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN DETERMINATION; HUMAN; LIVER DYSFUNCTION; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PREDICTION; QUESTIONNAIRE; RETROSPECTIVE STUDY; SELF REPORT; SOCIAL PSYCHOLOGY; WEIGHT REDUCTION;

EID: 4644325836     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.9.1185     Document Type: Article

References (18)

1. Prevalence of Overweight Among Children and Adolescents; United States, 1999. Washington, DC: National Center for Health Statistics, 2001.
2. Pinhas-Hamiel O, Dolan HM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996; 128: 608-615.
3. Jones K, Arslanian S, Peterokova V, Park J, Tomlinson M. Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002; 25: 89-94.
4. Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2000; 13: 1403-1409.
5. Brown FR Jr, Friskey RW, Kinsell LW, Michaels GD. Observations with sulfonylureas in diabetes. Metabolism 1956; 5: 864-867.
6. Fajans SS, Conn JW. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes 1960; 9: 83-88.
7. Owada M, Nitadori Y, Kitagawa T. Treatment of NIDDM in youth. Clin Pediatr 1988; 37: 117-122.
8. Chan NN, Feher MD, Bridges NA. Metformin therapy for diabetes in Prader-Willi syndrome. J Roy Soc Med 1998; 91: 598.
9. Turner RC, Cull CA, Frighi V, Holman R, UKPDS group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. JAMA 1999; 281: 2005-2012.
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 1999; 22 (Suppl 1): S32-S41.
12. Zuhri-Yafi MI, Brosnan PG, Hardin DS. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2002; 15 (Suppl 1): 541-546.
13. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
14. Srinivasan SR, Bao W, Wattigney WA, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 1996; 45: 235-240.
15. Sinaiko AR, Donahue RP, Jacobs DR, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999; 99: 1471-1476.
16. Bradshaw B. The role of the family in managing therapy in minority children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15 (Suppl 1): 547-551.
17. Laffel L, Vangsness L, Connell A, Goebel-Fabbr A, Butler D, Anderson BJ. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003; 142: 409-416.
18. Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB. Clinical and psychological course of diabetes from adolescence to young adulthood. Diabetes Care 2001; 24: 1536-1540.